Acorda Therapeutics (ACOR) Tops Q2 EPS by 27c
Tweet
Share
E-mailGet Alerts ACOR Hot Sheet
Price: $0.66 --0%
Financial Fact:
Provision for income taxes: -3.02M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Provision for income taxes: -3.02M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Acorda Therapeutics (NASDAQ: ACOR) reported Q2 EPS of $0.42, $0.27 better than the analyst estimate of $0.15. Revenue for the quarter came in at $97.13 million versus the consensus estimate of $91.4 million.
For earnings history and earnings-related data on Acorda Therapeutics (ACOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Cummins wins battery storage contract for U.S. data center project
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
